Taro Pharmaceutical Industries Ltd. (TARO)

75.94
0.18 0.24
NYSE : Health Technology
Prev Close 75.76
Open 75.94
Day Low/High 75.60 / 77.02
52 Wk Low/High 72.97 / 109.42
Volume 35.24K
Avg Volume 50.10K
Exchange NYSE
Shares Outstanding 38.54M
Market Cap 2.91B
EPS 7.20
P/E Ratio 10.45
Div & Yield N.A. (N.A)

Latest News

Taro Annual Report On Form 20-F Available For Fiscal Year Ended March 31, 2019

Taro Annual Report On Form 20-F Available For Fiscal Year Ended March 31, 2019

Taro Pharmaceutical Industries Ltd. (NYSE: TARO, "Taro") announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2019, filed with the Securities and Exchange Commission (the "SEC"), is available within the Investor Relations...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ATKR Downgrades: ACLS, AXE, CDNA, CTRN, CUBI, DNR, DXC, ERA, IMAX, IPHS, KNDI, MDP, SSP, TARO, ZVO Initiations: CDLX, DNLI Read on to get TheStreet Quant Ratings' detailed report:

Taro Provides Results For The Year Ended March 31, 2019

Taro Provides Results For The Year Ended March 31, 2019

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the quarter and year ended March 31, 2019.

Taro To Announce Full Year Results On May 22, 2019

Taro To Announce Full Year Results On May 22, 2019

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2019, on Wednesday, May 22, 2019.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BLMN, CIVB, CPSI, DRH, ENVA, HNI, KNL, LEN.B, PDFS, TARO, TYL Downgrades: ANH, AVP, CPAC, INVH, KODK, MNR, MX, NLY, PBF Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Taro Provides Results For December 31, 2018

Taro Provides Results For December 31, 2018

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") today provided unaudited financial results for the three and nine months ended December 31, 2018.

Taro To Announce Third Quarter Results On February 6, 2019

Taro To Announce Third Quarter Results On February 6, 2019

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended December 31, 2018, after the close of market on Wednesday, February 6, 2019.

Taro Announces Completion Of $250 Million Share Repurchase Program

Taro Announces Completion Of $250 Million Share Repurchase Program

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it has completed its $250 million share repurchase program.

Taro Provides Shareholders With Procedures Regarding Israeli Withholding Tax On Dividend

Taro Provides Shareholders With Procedures Regarding Israeli Withholding Tax On Dividend

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") announced today an explanation regarding taxation on the $500 million Special Dividend payable on December 28, 2018 to shareholders of record at the close of business on December...

Taro Provides Results For September 30, 2018

Taro Provides Results For September 30, 2018

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the three and six months ended September 30, 2018.

Taro To Announce Second Quarter Results On November 5, 2018

Taro To Announce Second Quarter Results On November 5, 2018

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2018, on Monday, November 5, 2018.

Taro Terminates Agreement With NovaBiotics

Taro Terminates Agreement With NovaBiotics

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") announced today that it has terminated the license agreement with NovaBiotics for the onychomycosis drug, Novexatin®.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANDE, BPI, CORE, ECHO, EPAY, FRD, HTBI, LAWS, MCY, MEDP, NMFC, NTES, PCRX, SCHL, SLG, SU, SWIR Downgrades: AKAM, AXU, DFRG, FFWM, IAG, IVC, MHK, RGNX, SRE, TARO, TWNK, UNFI, VECO Initiations: CGBD, SMHI, WTTR Read on to get TheStreet Quant Ratings' detailed report:

Taro Provides Results For Quarter Ended June 2018

Taro Provides Results For Quarter Ended June 2018

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the quarter ended June 30, 2018.

Taro To Announce First Quarter Results On August 9, 2018

Taro To Announce First Quarter Results On August 9, 2018

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on Thursday, August 9, 2018.

Taro Annual Report On Form 20-F Available

Taro Annual Report On Form 20-F Available

Taro Pharmaceutical Industries Ltd. (NYSE:TARO, "Taro") announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2018, filed with the Securities and Exchange Commission (the "SEC"), is available within the Investor Relations...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADM, AFSI, CKX, EML, EVH, GDEN, MVC, MYGN, PANW, SO, SYKE, TARO Downgrades: IRCP, RMCF, UEIC, WYND Initiations: CALA, FG, MTNB Read on to get TheStreet Quant Ratings' detailed report:

Taro Provides Results For Year Ended March 31, 2018

Taro Provides Results For Year Ended March 31, 2018

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the quarter and year ended March 31, 2018.

Taro To Announce Full Year Results On May 17, 2018

Taro To Announce Full Year Results On May 17, 2018

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for year ended March 31, 2018, on Thursday, May 17, 2018.

Taro Provides Results For December 31, 2017

Taro Provides Results For December 31, 2017

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the three and nine months ended December 31, 2017.

Taro To Announce Third Quarter Results On February 7, 2018

Taro To Announce Third Quarter Results On February 7, 2018

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2017, after the close of market on Wednesday, February 7,...

Taro Provides Results For September 30, 2017

Taro Provides Results For September 30, 2017

November 7, 2017-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the three and six months ended September 30, 2017.

Taro To Announce Second Quarter Results On November 7, 2017

Taro To Announce Second Quarter Results On November 7, 2017

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("TARO" or the "Company") announced today that it plans to release its financial results for the quarter and six months ended September 30, 2017, on Tuesday, November 7, 2017.

Taro Announces Joining Of CEO

Taro Announces Joining Of CEO

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") announced today that Mr.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BBSI, CAFD, CNXC, GNRT, GSBD, MCRN, RLGY, SBLK Downgrades: BGFV, BWINA, DGICA, HLIT, JACK, MDCO, RRGB, SOHO, TARO, TNC, VSAT, VSI, XRAY Initiations: LNTH, VTVT, WING Read on to get TheStreet Quant Ratings' detailed report:

Taro Provides Results For Quarter Ended June 2017

Taro Provides Results For Quarter Ended June 2017

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") today provided unaudited financial results for the quarter ended June 30, 2017.

Taro To Announce First Quarter Results On August 8, 2017

Taro To Announce First Quarter Results On August 8, 2017

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2017, after the close of market on Tuesday, August 8, 2017.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ATHN, NCR, PII, PM, TARO Downgrades: PBNC, SCS Initiations: HRI, SUPV Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: C (Hold)